ArticleScientific reports2026
NLRP1 promotes pyroptosis in endometriosis through the NF-κB signaling pathway.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Endometriosis is a prevalent gynecological disorder characterized by chronic inflammation. Pyroptosis, a type of programmed proinflammatory cell death, plays a crucial role in various inflammatory diseases. However, its specific mechanism in endometriosis remains unclear. This study integrated transcriptome data of patients with endometriosis from the GEO database with a pyroptosis-related gene set to identify core pyroptosis markers associated with endometriosis. Bioinformatics methods were employed to analyze the expression profiles and diagnostic values of these genes. The expression of these genes was validated in clinical specimens using qRT-PCR. The specific role of NLRP1 in endometriosis was subsequently explored using CCK-8, wound healing, Transwell, qRT-PCR and Western blot assays on cell lines. We identified eight pyroptosis markers closely related to endometriosis, among which the expression of NLRP1, PRKACA, and IL-6 were significantly upregulated in patients with endometriosis. The expression patterns of these genes were also confirmed in clinical specimens and cell lines. The results of functional experiments indicated that NLRP1 knockdown inhibited the proliferation, migration, and invasion of 12Z cells. Mechanistic studies revealed that downregulating NLRP1 expression reduced the expression of key molecules in the NF-κB signaling pathway and downstream caspase-1, GSDMD-N. This suggests that NLRP1 promotes pyroptosis by activating the NF-κB signaling pathway, thereby driving the progression of endometriosis. This study reveals a novel mechanism through which NLRP1 activates pyroptosis through the NF-κB signaling pathway and promotes the progression of endometriosis. NLRP1 may serve as a potential diagnostic biomarker and therapeutic target for endometriosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.